Roche Holding AG Stock
Your prediction
Roche Holding AG Stock
The price for the Roche Holding AG stock decreased slightly today. Compared to yesterday there is a change of -€2.800 (-0.720%).
Pros and Cons of Roche Holding AG in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Roche Holding AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Roche Holding AG | -0.720% | 0.051% | 7.052% | 35.306% | 6.876% | 57.967% | 57.967% |
| Beximco Pharmaceuticals Ltd. GDR | -0.940% | 2.941% | 16.667% | 22.664% | 17.188% | 20.413% | -40.341% |
| Eledon Pharmaceuticals Inc. | -1.380% | -9.375% | -13.690% | 8.209% | 126.563% | 137.705% | -46.789% |
| SELLAS Life Sciences Group Inc | 8.760% | -12.851% | -25.812% | 502.778% | 206.173% | 479.439% | 20.556% |
Comments
News
Madrigal Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Madrigal Pharmaceuticals, Inc.? Here are five stocks we like better.
- Rezdiffra sales rose 71% year over year to $364.3 million in Q2 2026, with nearly $1.3 billion in
Alnylam Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Alnylam Pharmaceuticals, Inc.? Here are five stocks we like better.
- Second-quarter revenue surged 74% to approximately $1.2 billion, driven by AMVUTTRA, which
The Hanover Insurance Group Q2 Earnings Call Highlights
The Hanover Insurance Group (NYSE:THG) reported record second-quarter operating performance, citing improved underwriting margins, accelerating premium growth and higher investment income across